Venus Remedies (BOM:526953) Research & Development: ₹182 Mil (TTM As of Mar. 2026)


BOM:526953 Venus Remedies Ltd BOM:526953
52 GF Score
Price ₹1,945.90
GF Value ₹467.09
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Venus Remedies Research & Development?

Venus Remedies BOM:526953 +4.99% 52 Research & Development is ₹182 Mil as of Mar. 2026. GuruFocus rates BOM:526953 with a GF Score™ of 52/100 and a GF Value™ of ₹467.09 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Venus Remedies's Research & Development for the three months ended in Mar. 2026 was ₹51 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹182 Mil.

Venus Remedies  (BOM:526953) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Venus Remedies Research & Development Related Terms

Venus Remedies Research & Development Historical Data

* Premium members only.

The historical data trend for Venus Remedies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Venus Remedies Research & Development Chart

Venus Remedies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 230.30 228.85 158.40 180.80 181.70

Venus Remedies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.90 39.90 43.50 47.30 51.00
BOM:526953
52GF Score
Venus Remedies Ltd BOM:526953
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Venus Remedies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹182 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹182 Mil mean?
Venus Remedies (BOM:526953) has a Research & Development of ₹182 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Venus Remedies and its competitors.
Is Venus Remedies' Research & Development too high?
Venus Remedies' current Research & Development is ₹182 Mil. Overall, Venus Remedies has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Venus Remedies' Research & Development compare to ZTS?
Venus Remedies' Research & Development of ₹182 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Venus Remedies and its competitors. Venus Remedies's current Research & Development is ₹182 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Venus Remedies stock overvalued right now?
Based on GuruFocus' analysis, Venus Remedies (BOM:526953) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹467.09, compared to a current price of ₹1,945.90 — trading 316.6% above its estimated fair value. The current Research & Development is ₹182 Mil. Venus Remedies' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Venus Remedies (BOM:526953), the current Research & Development is ₹182 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Venus Remedies (BOM:526953) Overvalued in 2026?

Based on GuruFocus' analysis, Venus Remedies stock appears to be overvalued. The current stock price of ₹1,945.90 is trading 316.6% above its estimated GF Value™ of ₹467.09. GuruFocus considers Venus Remedies to be Significantly Overvalued.

Key valuation signals for BOM:526953:

  • Research & Development: ₹182 Mil
  • GF Value™: ₹467.09 vs. price of ₹1,945.90 (316.6% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the BOM:526953 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Venus Remedies Business Description

Other Exchanges VENUSREM:India
Address Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.
52GF Score

Get the complete analysis for BOM:526953

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,945.90
Price
₹467.09
GF Value